Parkinson's disease Archives

Biomimesys

We will present our researches on the importance of ECM for drug discovery in Parkinson’s disease at NeuroFrance congress (May 19 to 21 )

The international NeuroFrance congress will take place May, 19, 20 and 21th 2021 (virtual meeting). On this occasion, our PhD student Véronique De Conto will present these works in a poster about the importance of matricial and cellular microenvironment for drug discovery in Parkinson’s disease (summary below). Feel free to Read more…

By Véronique De Conto, 3 yearsMay 14, 2021 ago

Biomimesys

Development of cerebral in vitro 3D models: update about Veronique’s PhD thesis

There are 90% of failure in clinical trials, mainly due to safety and efficiency issues. In particular, the central nervous system is involved in 34% of failure in clinical trials, but only in 7% of failure in preclinical trials (Cook et al., 2014). That points a lack of relevance in Read more…

By Véronique De Conto, 4 yearsOctober 13, 2020 ago

Biomimesys

A new version of BIOMIMESYS Brain is avaible to form neuronal network

The first version of BIOMIMESYS Brain allows to form neurospheres. We now developped a new version of BIOMIMESYS Brain, which allows to form neuronal networks. This version have a higher porosity than BIOMIMESYS Brain (Neurosphere), that allows to better disperse the cells and thus to form cell network instead of Read more…

By Véronique De Conto, 5 yearsMarch 5, 2019 ago